Here are two stocks with buy rank and strong momentum characteristics for investors to consider today, March 4th:
Option Care Health, Inc. OPCH: This home and alternate site infusion services company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 19.4% over the last 60 days.
Option Care Health, Inc. price-consensus-chart | Option Care Health, Inc. Quote
Option Care Health’s shares gained 49.5% over the last three months compared with the S&P 500’s decline of 3.7%. The company possesses a Momentum Score of A.
Option Care Health, Inc. price | Option Care Health, Inc. Quote
LeMaitre Vascular, Inc. LMAT: This medical devices and implants company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.8% over the last 60 days.
LeMaitre Vascular, Inc. price-consensus-chart | LeMaitre Vascular, Inc. Quote
LeMaitre Vascular’ shares gained 36.7% over the past year compared with the S&P 500’s advance of 15.2%. The company possesses a Momentum Score of A.
LeMaitre Vascular, Inc. price | LeMaitre Vascular, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
LeMaitre Vascular, Inc. (LMAT) : Free Stock Analysis Report
Option Care Health, Inc. (OPCH) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.